BVF INC/IL — SEC insider filings
SEC reporting owner CIK 1056807. 122 insider filings on record with FilingPulse; latest filed 2026-10-05.
Transaction summary — filings shown
Covers the 50 most recent of 122 filings on record, filed 2022-12-22 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 38 legs across 10 filings — 8,432,402 shares, $45,697,713 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 25 legs across 8 filings — 26,585,532 shares, $592,215,488 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 128.
- Largest priced transaction: sale of 8,974,245 shares @ $12.45 ($111,729,350) in POINT Biopharma Global Inc., filed 2023-12-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| POINT Biopharma Global Inc. (PNT) | — | 1 | — | 3 legs · 17,161,278 sh · $213,657,911 | — |
| Kymera Therapeutics, Inc. (KYMR) | Director | 9 | 13 legs · 772,279 sh · $20,507,864 | 4 legs · 1,630,658 sh · $173,665,077 | 9 |
| MoonLake Immunotherapeutics (MLTX) | Director, 10% owner | 6 | — | 6 legs · 5,750,000 sh · $162,965,700 | 4 |
| XOMA Royalty Corp (XOMA) | 10% owner | 6 | 4 legs · 22,249 sh · $420,737 | 6 legs · 1,043,440 sh · $27,626,507 | 13 |
| Third Harmonic Bio, Inc. (THRD) | — | 2 | 3 legs · 214,063 sh · $879,499 | 3 legs · 1,000,000 sh · $14,300,000 | — |
| Olema Pharmaceuticals, Inc. (OLMA) | Director | 7 | 3 legs · 1,505,932 sh · $14,818,371 | — | 20 |
| Repare Therapeutics Inc. (RPTX) | 10% owner | 3 | 9 legs · 2,011,010 sh · $9,071,242 | — | 3 |
| ESSA Pharma Inc. (EPIX) | 10% owner | 2 | — | 3 legs · 156 sh · $293 | 9 |
| Eledon Pharmaceuticals, Inc. (ELDN) | 10% owner | 3 | 6 legs · 3,906,869 sh | — | 12 |
| CTI BIOPHARMA CORP (CTIC) | Director, 10% owner | 2 | — | — | 19 |
+9 more issuers among the filings shown — every filing appears in the table below.
Insider filings — BVF INC/IL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 3 | Foghorn Therapeutics Inc. (FHTX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Holdings only — no transactions reported | EDGAR |
| 2026-09-18 | 4 | IMMUNIC, INC. (IMUX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 25,370 (derivative) @ $0 | EDGAR |
| 2026-07-16 | 4 | XOMA Royalty Corp (XOMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Code (U): 3,635,758 · Code (U): 2,773,545 · Code (U): 412,000 · Code (U): 772,000 | EDGAR |
| 2026-06-26 | 4 | Kymera Therapeutics, Inc. (KYMR) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Sale (S): 837,914 @ $106.50 · Sale (S): 627,597 @ $106.50 · Sale (S): 113,289 @ $106.50 · Sale (S): 51,858 @ $106.50 | EDGAR |
| 2026-06-25 | 4 | Kymera Therapeutics, Inc. (KYMR) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Olema Pharmaceuticals, Inc. (OLMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 29,500 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | MoonLake Immunotherapeutics (MLTX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 22,195 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | XOMA Royalty Corp (XOMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Conversion (C): 2,313,000 @ $4.03 · Conversion (C): 1,506,000 @ $4.03 · Conversion (C): 412,000 @ $4.03 · Conversion (C): 772,000 @ $4.03 · Conversion (C): 2,313 (derivative) @ $0 · Conversion (C): 1,506 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-02 | 4 | MoonLake Immunotherapeutics (MLTX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Sale (S): 1,932,354 @ $16.79 · Sale (S): 1,569,116 @ $16.79 · Sale (S): 248,530 @ $16.79 | EDGAR |
| 2026-01-30 | 4 | Repare Therapeutics Inc. (RPTX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Code (U): 5,309,432 · Code (U): 4,308,573 · Code (U): 548,938 | EDGAR |
| 2025-10-14 | 4 | ESSA Pharma Inc. (EPIX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Code (U): 6,194,145 · Code (U): 4,726,743 · Code (U): 560,797 | EDGAR |
| 2025-08-07 | 4 | ESSA Pharma Inc. (EPIX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Option exercise/expiry (X): 1,481,634 @ $0.00 · Option exercise/expiry (X): 1,235,030 @ $0.00 · Option exercise/expiry (X): 203,336 @ $0.00 · Sale (S): 79 @ $1.88 · Sale (S): 66 @ $1.88 · Sale (S): 11 @ $1.88 · +3 more | EDGAR |
| 2025-07-01 | 4 | Kymera Therapeutics, Inc. (KYMR) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 142,604 @ $44 · Purchase (P): 115,783 @ $44 · Purchase (P): 58,780 @ $44 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | GLYCOMIMETICS INC (CBIO) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Other (J): 657,308 · Other (J): 556,617 · Other (J): 56,079 · Other (J): 304,098 (derivative) · Other (J): 257,515 (derivative) · Other (J): 25,944 (derivative) | EDGAR |
| 2025-06-13 | 4 | Olema Pharmaceuticals, Inc. (OLMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 24,150 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | MoonLake Immunotherapeutics (MLTX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 6,682 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | XOMA Royalty Corp (XOMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Sale (S): 127,407 @ $27.10 · Sale (S): 265,316 @ $27.10 | EDGAR |
| 2025-05-19 | 4 | Allakos Inc. (ALLK) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Disposition to issuer (D): 8,679,726 · Disposition to issuer (D): 6,777,935 · Disposition to issuer (D): 855,211 | EDGAR |
| 2025-01-28 | 4 | XOMA Royalty Corp (XOMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Sale (S): 339,679 @ $26.10 · Sale (S): 85,776 @ $26.10 · Sale (S): 75,287 @ $26.10 · Sale (S): 149,975 @ $26.10 | EDGAR |
| 2025-01-14 | 4 | Olema Pharmaceuticals, Inc. (OLMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Disposition to issuer (D): 235,450 · Disposition to issuer (D): 161,810 · Disposition to issuer (D): 22,740 · Grant/award (A): 235,450 (derivative) · Grant/award (A): 161,810 (derivative) · Grant/award (A): 22,740 (derivative) | EDGAR |
| 2024-12-17 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Other (J): 234,323 · Other (J): 174,958 · Other (J): 29,648 | EDGAR |
| 2024-12-04 | 4 | Olema Pharmaceuticals, Inc. (OLMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Disposition to issuer (D): 1,797,527 · Disposition to issuer (D): 1,418,736 · Disposition to issuer (D): 153,441 · Grant/award (A): 1,797,527 (derivative) · Grant/award (A): 1,418,736 (derivative) · Grant/award (A): 153,441 (derivative) · +3 more | EDGAR |
| 2024-11-13 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Other (J): 3,062,000 · Other (J): 2,378,000 · Other (J): 240,000 · Other (J): 3,062,000 (derivative) · Other (J): 2,378,000 (derivative) · Other (J): 240,000 (derivative) | EDGAR |
| 2024-10-31 | 4 | Eledon Pharmaceuticals, Inc. (ELDN) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 2,213,816 (derivative) @ $3.65 · Purchase (P): 2,100,244 (derivative) @ $3.65 · Purchase (P): 440,489 (derivative) @ $3.65 | EDGAR |
| 2024-10-31 | 4 | Third Harmonic Bio, Inc. (THRD) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Sale (S): 538,420 @ $14.30 · Sale (S): 396,963 @ $14.30 · Sale (S): 64,617 @ $14.30 | EDGAR |
| 2024-10-08 | 4 | MoonLake Immunotherapeutics (MLTX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Sale (S): 1,030,589 @ $50.00 · Sale (S): 836,862 @ $50.00 · Sale (S): 132,549 @ $50.00 | EDGAR |
| 2024-08-22 | 4 | Kymera Therapeutics, Inc. (KYMR) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 201,546 (derivative) @ $40.75 · Purchase (P): 156,742 (derivative) @ $40.75 | EDGAR |
| 2024-06-28 | 4 | Kymera Therapeutics, Inc. (KYMR) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Olema Pharmaceuticals, Inc. (OLMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | MoonLake Immunotherapeutics (MLTX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 7,688 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | Eledon Pharmaceuticals, Inc. (ELDN) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 1,031,385 · Purchase (P): 821,121 · Purchase (P): 75,431 · Purchase (P): 3,173,135 (derivative) · Purchase (P): 2,526,238 (derivative) · Purchase (P): 232,068 (derivative) | EDGAR |
| 2024-01-29 | 4 | Rain Oncology Inc. (RAIN) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Code (U): 1,734,960 · Code (U): 2,870,985 · Code (U): 1,367,838 · Code (U): 2,076,085 · Code (U): 185,388 · Code (U): 341,547 · +2 more | EDGAR |
| 2024-01-09 | 4 | Kymera Therapeutics, Inc. (KYMR) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 550,425 (derivative) @ $25.25 · Purchase (P): 375,856 (derivative) @ $25.25 · Purchase (P): 52,733 (derivative) @ $25.25 | EDGAR |
| 2023-12-20 | 4 | POINT Biopharma Global Inc. (PNT) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Sale (S): 8,974,245 @ $12.45 · Sale (S): 7,290,667 @ $12.45 · Sale (S): 896,366 @ $12.45 | EDGAR |
| 2023-11-17 | 4 | Repare Therapeutics Inc. (RPTX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 493,337 @ $5.00 · Purchase (P): 390,507 @ $5.00 · Purchase (P): 47,712 @ $5.00 · Purchase (P): 153,693 @ $5.38 · Purchase (P): 125,909 @ $5.38 · Purchase (P): 16,143 @ $5.38 | EDGAR |
| 2023-11-06 | 4 | Kymera Therapeutics, Inc. (KYMR) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 57,618 @ $11.64 · Purchase (P): 132,016 @ $11.64 · Purchase (P): 26,772 @ $11.64 · Purchase (P): 103,885 @ $14.07 · Purchase (P): 83,708 @ $14.07 · Purchase (P): 10,106 @ $14.07 | EDGAR |
| 2023-11-03 | 4 | Repare Therapeutics Inc. (RPTX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 218,979 @ $3.60 · Purchase (P): 492,251 @ $3.60 · Purchase (P): 72,479 @ $3.60 | EDGAR |
| 2023-09-14 | 4 | Olema Pharmaceuticals, Inc. (OLMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 775,278 @ $9.84 · Purchase (P): 677,853 @ $9.84 · Purchase (P): 52,801 @ $9.84 · Other (J): 99,556 | EDGAR |
| 2023-06-28 | 4 | CTI BIOPHARMA CORP (CTIC) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Code (U): 3,989,130 @ $9.10 · Code (U): 2,595,239 @ $9.10 · Code (U): 702,505 @ $9.10 · Code (U): 1,526,147 @ $9.10 · Code (U): 43,139 @ $9.10 · Code (U): 1,594 (derivative) · +12 more | EDGAR |
| 2023-06-21 | 4 | Olema Pharmaceuticals, Inc. (OLMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 21,520 (derivative) @ $0 | EDGAR |
| 2023-06-20 | 4 | Kymera Therapeutics, Inc. (KYMR) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2023-06-12 | 4 | MoonLake Immunotherapeutics (MLTX) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 11,297 (derivative) @ $0 | EDGAR |
| 2023-05-19 | 4 | XOMA Corp (XOMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 10,967 (derivative) @ $0 | EDGAR |
| 2023-05-12 | 4 | Structure Therapeutics Inc. (GPCR) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Other (J): 4,018,253 · Other (J): 2,929,660 · Other (J): 462,605 · Other (J): 4,018,253 (derivative) · Other (J): 2,929,660 (derivative) · Other (J): 462,605 (derivative) | EDGAR |
| 2023-05-09 | 4 | Eledon Pharmaceuticals, Inc. (ELDN) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 1,055,445 · Purchase (P): 837,146 · Purchase (P): 86,341 · Purchase (P): 2,028,645 (derivative) · Purchase (P): 1,609,063 (derivative) · Purchase (P): 165,950 (derivative) · +3 more | EDGAR |
| 2023-04-07 | 4 | CTI BIOPHARMA CORP (CTIC) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2023-01-19 | 4 | Cullinan Oncology, Inc. (CGEM) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Other (J): 3,500,000 · Other (J): 2,600,000 · Other (J): 300,000 · Other (J): 350,000 (derivative) · Other (J): 260,000 (derivative) · Other (J): 30,000 (derivative) | EDGAR |
| 2023-01-13 | 4 | Kymera Therapeutics, Inc. (KYMR) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 10,961 @ $29.89 · Purchase (P): 11,149 @ $29.89 · Purchase (P): 2,985 @ $31.24 · Purchase (P): 15,912 @ $31.24 | EDGAR |
| 2023-01-09 | 4 | XOMA Corp (XOMA) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 3,330 @ $18.39 · Purchase (P): 1,676 @ $21.98 · Purchase (P): 15,670 @ $18.39 · Purchase (P): 1,573 @ $21.98 | EDGAR |
| 2022-12-22 | 4 | Third Harmonic Bio, Inc. (THRD) jointly with BVF PARTNERS L P/IL, BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, LAMPERT MARK N | Purchase (P): 116,635 @ $4.11 · Purchase (P): 87,831 @ $4.11 · Purchase (P): 9,597 @ $4.11 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1056807 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs